Abhigra

Product Overview

Abhigra Tablet is a pharmaceutical formulation containing Sildenafil as its active component. This medication is extensively prescribed for the management of erectile dysfunction (ED) in male patients. As a phosphodiesterase type 5 (PDE5) inhibitor, Abhigra Tablet enhances penile blood circulation during sexual stimulation, thereby facilitating improved erectile capability. The tablet is designed to provide rapid symptom relief, enabling satisfactory sexual performance.

Therapeutic Indications

Abhigra Tablet is indicated for the treatment of erectile dysfunction, a prevalent condition marked by the persistent inability to attain or sustain an erection adequate for sexual intercourse. This medication assists adult males of varying age groups in restoring sexual confidence and achieving gratifying intimate relationships.

Administration Guidelines

For optimal results, ingest Abhigra Tablet intact with water approximately 30-60 minutes prior to anticipated sexual activity. Consumption with heavy or fatty meals should be avoided as this may delay therapeutic onset. The tablet should not be crushed, chewed, or divided. Strictly adhere to the prescribed dosage regimen of one tablet per 24-hour period as directed by a medical practitioner.

Mechanism of Action

Sildenafil, the active pharmaceutical ingredient in Abhigra Tablet, exerts its therapeutic effect through selective inhibition of phosphodiesterase type 5 (PDE5) enzymes. During sexual stimulation, nitric oxide-mediated activation of guanylate cyclase increases cyclic guanosine monophosphate (cGMP) levels, promoting vasodilation of penile vasculature. PDE5 inhibition by Abhigra Tablet potentiates this physiological response, enhancing blood flow to erectile tissues.

Dosage Protocol

The standard therapeutic regimen consists of a single 50mg or 100mg tablet administered as required, with a minimum 24-hour interval between doses. Dosage adjustment should be based on individual therapeutic response and tolerability profile. Strict adherence to prescribing physician’s instructions is imperative, and dosage escalation beyond recommended limits is contraindicated.

Therapeutic Advantages

Abhigra Tablet provides multiple clinical benefits for ED patients, including rapid onset of action and restoration of natural erectile function. The medication supports psychological well-being by improving self-confidence and interpersonal relationships. Its efficacy in facilitating satisfactory sexual performance contributes to enhanced quality of life.

Adverse Effects

Common adverse reactions may include cephalalgia, facial erythema, dyspepsia, rhinitis, vertigo, and visual disturbances. These effects are typically transient and mild-to-moderate in intensity. Persistent or severe symptoms warrant immediate medical consultation.

Precautions

Abhigra Tablet is contraindicated in patients with cardiovascular disorders, hepatic/renal impairment, or those receiving nitrate therapy. A comprehensive medical evaluation is essential prior to initiation of therapy to assess individual suitability and potential drug interactions.

Storage Conditions

Maintain Abhigra Tablet at ambient temperature (15°C-30°C) in a dry environment protected from light and humidity. Retain in original packaging and store beyond the reach of children and animals. Discard any medication beyond its printed expiration date.

Disclaimer:

The provided information is intended for educational purposes and has undergone expert medical review. This content should not substitute professional medical advice, diagnosis, or treatment. The complete safety profile, including potential drug interactions and contraindications, may not be fully detailed herein. Always consult qualified healthcare providers for personalized medical guidance. This information aims to complement, not replace, the physician-patient relationship.